Prism Ideas opens North American office in global growth strategy
10 March 2011 | By The Scott Partnership
Prism Ideas, today announced the opening of its first North American office in Boston, Massachusetts...
List view / Grid view
10 March 2011 | By The Scott Partnership
Prism Ideas, today announced the opening of its first North American office in Boston, Massachusetts...
10 March 2011 | By Pfizer
View and listen to a webcast of a presentation by Mikael Dolsten, President, Worldwide R&D...
10 March 2011 | By kdm communications limited
Sigma Life Science,has announced the addition of 1,400 new ECACC cell lines to its collection of cell line cultures and services...
9 March 2011 | By Novartis
An advisory committee recommended that the FDA approve QAB149 (indacaterol) in the US...
9 March 2011 | By Resolute Communications
XEPLION®, has received approval from the European Commission for the treatment of schizophrenia...
9 March 2011 | By Eli Lilly and Company
According to John Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company...
8 March 2011 | By AstraZeneca
The US FDA has accepted for review a New Drug Application (NDA) for dapagliflozin...
7 March 2011 | By The Scott Partnership
Find them on booth #1121 at the American Chemical Society (ACS) National Exposition, 27-31 March, 2011, Anaheim, CA...
7 March 2011 | By BMG LABTECH
Win the first of five free free SPECTROstar Nano absorbance microplate readers...
7 March 2011 | By GlaxoSmithKline
Patients living in Scotland with renal cell carcinoma, will have access to a new treatment choice, as Votrient® (pazopanib)...
3 March 2011 | By The Scott Partnership
To accommodate demand for its RapidFACT Service...
3 March 2011 | By The Scott Partnership
PRECOS will be discussing in vitro and in vivo modeling of the human TME...
2 March 2011 | By HACH LANGE
Did you know that there is a new 100LPM MET ONE Particle Counter available from HACH LANGE?...
2 March 2011 | By GlaxoSmithKline
New plans to encourage students graduating from UK to consider a career with GSK...
2 March 2011 | By Roche
Avastin in combination with paclitaxel will remain a treatment option for women with metastatic breast cancer in Europe...